The Acute Myeloid Leukemia Channel is supported with funding from BMS (Silver), and through an educational grant from Jazz Pharmaceuticals.
The Myelodysplastic Syndromes Channel is supported with funding from Geron (Silver).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ISAL 2019 | Clonal hematopoiesis of indeterminate potential (CHIP): genes, disease predisposition & potential
Siddhartha Jaiswal, MD, PhD, of Stanford University, Stanford, CA, discusses the interesting new field of clonal hematopoiesis of indeterminate potential (CHIP) and its role in leukemogenesis. Dr Jaiswal covers who this affects, what genes are most commonly mutated in the process, its effect on disease predisposition, and the potential to target it in the future. This interview took place at the International Symposium on Acute Leukemias (ISAL) 2019, held in Munich, Germany.
